ArticleCurrent oncology (Toronto, Ont.)2019

Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy.

M Dosani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.